Percutaneous coronary intervention: basic principles and guidelines

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Synonyms and keywords: PCI; balloon angioplasty; percutaneous transluminal angioplasty

Heart Team Approach to Revascularization Decisions | Left Main Coronary Artery Disease | Non-Left Main Coronary Artery Disease | Revascularization to Improve Symptoms | Dual Antiplatelet Therapy Compliance and Stent Thrombosis | Hybrid Coronary Revascularization

Contrast-Induced Acute Kidney Injury | Anaphylactoid Reactions | Statin Treatment | Bleeding Risk | Role of Onsite Surgical Backup

• Vascular Access
• PCI in Specific Clinical Situations:
  • Asymptomatic Ischemia or CCS Class I or II Angina
  • CCS Class III Angina
  • Unstable Angina/Non–ST-Elevation Myocardial Infarction
  • ST-Elevation Myocardial Infarction: General and Specific Considerations | Coronary Angiography Strategies in STEMI | Primary PCI of the Infarct Artery | Delayed or Elective PCI in patients with STEMI | Fibrinolytic-Ineligible Patients | Facilitated PCI | Rescue PCI | After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
• Cardiogenic Shock
• Prior Coronary Bypass Surgery
• Revascularization Before Non-cardiac Surgery
• Adjunctive Diagnostic Devices: Fractional Flow Reserve | Intravascular Ultrasound
• Adjunctive Therapeutic Devices: Coronary Atherectomy | Thrombectomy | Laser Angioplasty | Cutting Balloon Angioplasty | Embolic Protection Devices
• Percutaneous Hemodynamic Support Devices
• Antiplatelet therapy:
  • Oral Antiplatelet Therapy
  • Glycoprotein IIb/IIIa Receptor Antagonists
  • Intravenous Antiplatelet therapy: STEMI | UA/NSTEMI | SIHD
• Anticoagulant Therapy: Parenteral Anticoagulants During PCI | Unfractionated Heparin | Enoxaparin | Bivalirudin and Argatroban | Fondaparinux | No-Reflow Pharmacological Therapies
• PCI in Specific Anatomic Situations: Chronic Total Occlusions | Saphenous Vein Grafts | Bifurcation Lesions | Aorto-Ostial Stenoses | Calcified Lesions
• PCI in Specific Patient Populations: Chronic Kidney Disease
• Peri-procedural Myocardial Infarction Assessment
• Vascular Closure Devices

• Post-procedural Antiplatelet Therapy
• Proton Pump Inhibitors and Antiplatelet Therapy
• Clopidogrel Genetic Testing
• Platelet Function Testing
• Restenosis
• Exercise Testing
• Cardiac Rehabilitation

Quality and Performance | Certification and Maintenance of Certification | Operator and Institutional Competency and Volume

Template:WikiDoc Sources